4.8 Article

Epistasis, aneuploidy, and functional mutations underlie evolution of resistance to induced microtubule depolymerization

Journal

EMBO JOURNAL
Volume 40, Issue 22, Pages -

Publisher

WILEY
DOI: 10.15252/embj.2021108225

Keywords

chromosome segregation; laboratory evolution; microtubule dynamics; resistance to antimitotics

Funding

  1. AIRC, the Italian association for cancer research [AIRC-IG 21556, AIRC-IG 23258]
  2. AIRC fellowship
  3. Italian Ministry of Health
  4. Fondazione Umberto Veronesi fellowship
  5. National Research, Development and Innovation Office of Hungary [FK 128775]
  6. Janos Bolyai Research Fellowship from the Hungarian Academy of Sciences [BO/779/20]
  7. New National Excellence Program of the Hungarian Ministry of Human Capacities (Bolyai+) [UNKP-20-5-SZTE-646, UNKP-21-5-SZTE-562]
  8. National Research, Development and Innovation Fund of Hungary [K_124881, FIEK_16-1-2016-0005]
  9. Singapore NRF Investigatorship [NRF-NRFI05-2019-0008]
  10. Hungarian Academy of Sciences

Ask authors/readers for more resources

Cells with blocked microtubule polymerization can eventually proliferate despite chromosome missegregation, and through laboratory evolution, they can regain the ability to form microtubules and become less sensitive to microtubule-depolymerizing drugs. The study identified recurrently mutated genes, particularly for tubulins and kinesins, as well as duplication of chromosome VIII, which allowed cells to compensate for the original mutation. Analysis revealed a consistent series of events in the development of resistance, indicating the importance of chromosome duplication followed by adaptive mutations in tubulins or kinesins.
Cells with blocked microtubule polymerization are delayed in mitosis, but eventually manage to proliferate despite substantial chromosome missegregation. While several studies have analyzed the first cell division after microtubule depolymerization, we have asked how cells cope long-term with microtubule impairment. We allowed 24 clonal populations of yeast cells with beta-tubulin mutations preventing proper microtubule polymerization, to evolve for similar to 150 generations. At the end of the laboratory evolution experiment, cells had regained the ability to form microtubules and were less sensitive to microtubule-depolymerizing drugs. Whole-genome sequencing identified recurrently mutated genes, in particular for tubulins and kinesins, as well as pervasive duplication of chromosome VIII. Recreating these mutations and chromosome VIII disomy prior to evolution confirmed that they allow cells to compensate for the original mutation in beta-tubulin. Most of the identified mutations did not abolish function, but rather restored microtubule functionality. Analysis of the temporal order of resistance development in independent populations repeatedly revealed the same series of events: disomy of chromosome VIII followed by a single additional adaptive mutation in either tubulins or kinesins. Since tubulins are highly conserved among eukaryotes, our results have implications for understanding resistance to microtubule-targeting drugs widely used in cancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available